Reaction

Dysmorphism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,350 reports · 46 co-occurring drugs

As of the last recalculation, Dysmorphism appears in 2,350 FAERS reports alongside 46 co-occurring drug terms. The strongest observed disproportionality signal is VALPROATE SODIUM (PRR 198.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Valproate Sodium	387	198.3	202.1
Valproic Acid	188	57.3	57.7
Misoprostol	30	27.6	27.7
Lopinavir And Ritonavir	40	26.6	26.6
Lamotirigine	189	25.3	25.4
Lamotrigine Extended-Release	189	25.3	25.4
Lamotrigine Chewable Dispersible	189	25.3	25.4
Carbamazepine	161	22.8	22.8
Methimazole	18	20.5	20.5
Phytonadione	19	20.0	20.0
Phenobarbital	29	17.9	18.0
Nevirapine	17	16.8	16.8
Lamotrigine	227	16.8	16.8
Phenytoin	38	16.4	16.4
Ampicillin	14	15.1	15.1
Ampicillin Sodium	14	15.1	15.1
Levetiracetam In Sodium Chloride	115	13.8	13.8
Levetiracetam Oral	115	13.8	13.8
Levetiracetam Injection	115	13.8	13.8
Divalproex Sodium	68	13.3	13.3
Efavirenz	16	12.8	12.8
Ziprasidone	24	12.2	12.2
Clobazam	32	11.8	11.8
Levetiracetam	162	11.5	11.5
Folic Acid	285	11.4	11.4
Epoetin Alfa	15	11.3	11.3
Oxcarbazepine	40	11.1	11.1
Zonisamide	18	10.9	10.9
Tenofovir Disoproxil Fumarate Tablets	10	10.3	10.3
Atazanavir	16	9.9	9.9
Topiramate	90	8.9	8.9
Ritonavir	27	8.3	8.3
Zidovudine	12	8.0	8.0
Paroxetine Hydrochloride	76	7.6	7.6
Sevoflurane	6	6.4	6.4
Vigabatrin	10	6.1	6.1
Lamivudine Oral	17	6.0	6.0
Lamivudine	18	5.2	5.2
Emtricitabine And Tenofovir Disoproxil Fumarate	25	4.9	4.9
Pyrazinamide	5	4.7	4.7
Darunavir	8	4.7	4.7
Lacosamide	17	4.1	4.1
Isotretinoin	22	4.0	4.0
Dolutegravir Sodium	4	3.9	3.9
Tenofovir Disoproxil Fumarate	11	3.0	3.0
Etonogestrel	6	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.